GI Dynamics has been increasing its activity lately by raising offerings and getting favorable data published for its EndoBarrier, an obesity treatment device.
Bardy Diagnostics unveiled its artificial intelligence solution that can detect atrial fibrillation events at the 39th annual meeting of the Heart Rhythm Society.
Murj has raised $8.5 million in a series B round to help increase marketing and sales efforts for its ICD data-monitoring solution.
Cook Medical concluded a 10-year-journey this week after it received approval of its Hemospray in the U.S. to treat gastrointestinal bleeds.
Myriad Genetics presented results from a 24-week study that showed Major Depressive Disorder patients were 50% more likely to achieve remission and 30% more likely to respond to treatment using the GeneSight Psychotropic genetic test.
BrainsWay just recently snagged FDA clearance for a new stimulator to be used in the Deep Transcranial Magnetic Stimulation System.
Integer will now turn its attention to its Cardio & Vascular and Cardiac & Neuromodulation offerings.
Hologic saw a 10% increase in revenue for 2Q18, but its Cynosure aesthetic business did not perform as well as expected, causing the company to lower revenue guidance for the year.
Qure.ai is the next company in line to develop an AI-based technology that can help spot trauma in a patient’s CT scan.
LivaNova topples Wall Street consensus on sales and EPS in its first quarter, but sees dip in shares.
Fitbit has chosen Google Cloud to help with an interoperability solution that enables users to collaborate on care with healthcare providers.
ProLung is hoping to change the way lung cancer is detected through its test that measures the difference in conductivity between malignant and benign lung tissue.